Breaking Down BioGenerator

How Arch Grant’s Recipient Hemadvance Attracted its Startup Dream Team

Adarza BioSystems Raises $5 Million in Series B Investment Round

BioGenerator Company Accuronix Targets Pancreatic Cancer

Robert Beardsley on Galera Therapeutics’ High Growth

Capital Ideas: Jay Schmelter of RiverVest

Life Sciences in St. Louis: Q/A with Rick Ryan, General Partner of Cultivation Capital

That’s Life (Sciences)

International Affair

Sam Altman of Y Combinator: “We Want To Hire More St. Louis Startups.”